Joseph A. Baur
Works at
Associate professor of physiology
Sources: reporter.nih.gov
Grants and prizes
U01, Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization, U01AG089107, 2024–2029, 28 Aug 2026
R01, Role of Activin Type II Receptor Signaling in Muscle Physiology, Weight Loss and Aging, R01AG094130, 2026–2031, 24 Jul 2026
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging, R01DK098656, 2013–2029, 15 Dec 2025
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Role of Activin Type II Receptor Signaling in Muscle Hypertrophy, Obesity, and Weight Loss, R01DK139663, 2024–2029, 15 Dec 2025
National Institute of Neurological Disorders and Stroke
R33, HTS to identify compounds that increase NAD+ levels in neurons and muscle cells, R33NS111375, 2022–2025, 6 Jun 2023
Sources: reporter.nih.gov